# Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

> **NCT04148105** · PHASE4 · TERMINATED · sponsor: **Henry Ford Health System** · enrollment: 19 (actual)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Cilostazol 100 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04148105
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-01
- **Primary completion:** 2023-05-21
- **Final completion:** 2023-05-26
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148105, "Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04148105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*